By Judith Wenshuk, peptide research writer
Quick Answer: SS-31 (elamipretide) is a mitochondrial-targeted peptide, studied for its role in protecting mitochondrial membrane integrity and supporting cellular energy production. It’s one of the newer, more targeted compounds in cellular-health research, with a research focus distinct from broader metabolic compounds like NAD+.
SS-31 is designed to concentrate specifically within mitochondria, making it one of the more precisely targeted compounds in this research category. It’s available in Canada through research peptide suppliers for laboratory study.
How It Works
SS-31 is studied for its ability to bind to cardiolipin, a lipid found specifically in the inner mitochondrial membrane, where it’s believed to help maintain membrane structure and function. This targeted mechanism is what distinguishes it from broader-acting compounds like NAD+ or MOTS-c.
What It’s Studied For
- Mitochondrial membrane research — its core, defining mechanism
- Cellular energy production research — tied to healthy mitochondrial function
How It Compares to Other Mitochondrial Compounds
SS-31, MOTS-c, and NAD+ are all studied in mitochondrial and cellular-energy research contexts, but each targets a different part of the process — SS-31 focuses on membrane structure specifically, while MOTS-c and NAD+ relate more broadly to metabolic signaling and energy production.
Frequently Asked Questions
Is SS-31 the same as MOTS-c? No — both relate to mitochondrial research, but SS-31 targets membrane structure specifically, while MOTS-c is a mitochondrial-DNA-encoded peptide with a broader metabolic role.
Is SS-31 available as a research compound in Canada? Yes — SS-31 is available through research peptide suppliers in Canada.